Afatinib Targeted Therapy Affects the Immune Function and Serum Levels of EGFR and Gastrin-Releasing Peptide Precursor (pro-GRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC)

OBJECTIVE: This study is aimed at investigating the clinical intervention effect of afatinib targeted therapy in patients with non-small-cell lung cancer. METHODS: The research object was a retrospective analysis of 86 patients with non-small-cell lung cancer who were admitted to our hospital from 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wei, Ma, Jun, Jiang, Xuan, Gao, Guangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492325/
https://www.ncbi.nlm.nih.gov/pubmed/36157204
http://dx.doi.org/10.1155/2022/2869531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492325/
https://www.ncbi.nlm.nih.gov/pubmed/36157204
http://dx.doi.org/10.1155/2022/2869531

Ejemplares similares